私人股权公司以11亿美元的价格购买Avid Bioservices,以促进其生物工程制造业的增长。 Private equity firms buy Avid Bioservices for $1.1 billion to boost its biologics manufacturing growth.

Avid Bioservices是一家生物制造公司,被私人股权公司GHO Capital和Ampersand Capital Partners收购,价值约11亿美元。 Avid Bioservices, a biologics manufacturing company, was acquired by private equity firms GHO Capital and Ampersand Capital Partners for about $1.1 billion. 这项收购旨在通过扩大其服务、投资于人才和增加其全球存在,支持Avid的增长。 This acquisition aims to support Avid's growth by expanding its services, investing in talent, and increasing its global presence. GHO和Ampersand在CDMO部门拥有广泛的经验,这将有助于Avid的发展和市场扩张。 GHO and Ampersand have extensive experience in the CDMO sector, which will aid Avid's development and market expansion.